These remarkable effects underline the necessity of a better understating of the biological behavior of IL-26 and its role in the pathophysiology and disease burden in several smoking-related airway inflammatory disorders, such as COPD and chronic bronchitis. Here, IL26 is linked to chronic obstructive pulmonary disease.